Cor.At Tox / Troponin Release Assay

Emetine d3

Cor.At® mouse stem cell-derived cardiomyocytes provide a predictive, standardized, and reproducible cell system for the in vitro assessment of structural carditoxicity (e.g. viability, metabolic impairment). After incubation with test compounds, end points such as neutral red uptake can be used to determine effects which directly affect the viability and integrity of cardiac cells when compared to a non-specific reference cell type, e.g. mouse fibroblasts (see Cor.At@ Tox Neutral Red Uptake assay).

Since cardiac Troponin is considered to be the gold standard biomarker for cardiac injury [1,2], e.g. after myocardial infarction, we have established a cardiac toxicity assay using Cor.At® cardiomyocytes in our standard Cor.At® Tox set-up, but with Troponin release as read-out. 
After compound treatment, supernatant is collected at various time points (e.g. after 24h, 48h, and 72h), and the amount of Troponin is quantified using a high sensitiviy mouse cardiiac troponin I ELISA kit (e.g. Life Diagnostics, Inc., Cat. No. 2010 1 HS). Troponin release from treated wells is then compared to vehicle-treated, time-mached controls. 

[1] Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals
P J O’Brien1, D E C Smith1, T J Knechtel2, M A Marchak2, I Pruimboom-Brees3, D J Brees3, D P Spratt4, F J Archer4, P Butler5, A N Potter1, J P Provost6, J Richard6, P A Snyder3 and W J Reagan3
Laboratory Animals Ltd. Laboratory Animals (2006) 40, 153–171

[2] Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity
Kendall B. Wallace, Elizabeth Hausner, Eugene Herman, Gordon D. Holt, James T. Macgregor, Alan L. Metz, Elizabeth Murphy, I.Y. Rosenblum, Frank D. Sistare and Malcolm J. York
Toxicol Pathol 2004; 32; 106

Advantages of the Cor.At Tox / Troponin Release Assay

  • Predictive, relevant and robust test system capable of medium to high throughput screening.
  • Gold standard biomarker of cardiac injury as read-out in a high-sensitivity ELISA format.
  • Either standardized or customized protocols available with respect to drug treatment periods; multiple sampling timepoints per treatment possible
  • Can be combined with NRU assay (Cor.At Tox test)
  • Comparison with effects on cardiac electrophysiology and mitochondrial function within the same cell system possible.


Nattermannallee 1, Bldg S20
50829 Cologne
Germany –  (Map)

600 W Germantown Pike, Suite 110
Plymouth Meeting, PA 19462
USA – (Map)




Twitter:  |   LinkedIn:  |   Newsletter:  Subscribe Axiogenesis Newsletter


Phone (Main)
+49 221 99 88 18-0

Phone (US)
+1 844-511-6959

Fax + 49 221 99 88 18-10